7th Myeloid-Directed Summit 2025, November 18-20, 2025
Conference
genOway presentation
Event
-
November 18, 2025
genOway's presentation on Wednesday, November 19, 2025 | 11 a.m. EST:
How to enhance translatability of myeloid-targeted therapies in preclinical models
- Human immune cells are recruited, differentiate and polarize in the tumor microenvironment (TME) of genO-BRGSF-HIS mouse model based on tumor type and tumor burden
- genO-BRGSF-HIS mice recapitulates the pathophysiology of inflammatory diseases
- genO-BRGSF-HIS mouse model is a valuable tool to investigate immune-related adverse events induced by immunotherapies
7th Myeloid-Directed Summit 2025, November 18-20, 2025
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Featured in 600+ scientific articles
Collaborative approach
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Robust validation data on catalog models
Generated with biopharma partners and in-house
Innovative technologies
and guaranteed freedom to operate
Easy access to models
Models with certified health status from professional breeders in US and Europe